Christopher U. Missling - 11 Sep 2025 Form 4 Insider Report for ANAVEX LIFE SCIENCES CORP. (AVXL)

Reporting relationship: President and CEO, Director
Issuer ticker: AVXL
Reported as of: 11 Sep 2025
Net transaction value: -$444,560
SEC form: 4
Accepted by SEC: 12 Sep 2025, 19:00:34 UTC
Prior SEC filing: 22 Aug 2025
Next SEC filing: 03 Oct 2025
Source filing: View source filing
Reporting owner signature: /s/Christopher Missling

Key filing fact

Christopher U. Missling filed Form 4 for ANAVEX LIFE SCIENCES CORP. (AVXL) on 12 Sep 2025.

Key facts

This page summarizes Christopher U. Missling's Form 4 filing for ANAVEX LIFE SCIENCES CORP. (AVXL).
3 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 12 Sep 2025, 19:00.

Change

Previous filing in this sequence was filed on 22 Aug 2025.
Current net transaction value: -$444,560.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001196573 Primary reporting owner

MISSLING CHRISTOPHER U

Relationship: President and CEO, Director
Address: 630 5TH AVENUE, 20TH FLOOR, NEW YORK
Signature: /s/Christopher Missling
Signature date: 12 Sep 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

AVXL transaction

Common Stock

Options Exercise

Transaction value: $945,000
Shares: +187,500
Change %: +13%
Price: $5.04
Shares after: 1,655,213
Date: 11 Sep 2025
Ownership: Direct

AVXL transaction

Common Stock

Tax liability

Transaction value: $1,389,560
Shares: -145,048
Change %: -8.8%
Price: $9.58
Shares after: 1,510,165
Date: 11 Sep 2025
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

AVXL transaction Derivative

Stock Option (Right to Buy)

Options Exercise

Transaction value: $0
Shares: -187,500
Change %: -100%
Price: $0.000000
Shares after: 0
Date: 11 Sep 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 187,500
Exercise price: $5.04

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Represents a "net exercise" of outstanding stock options, which options were scheduled to expire on September 18, 2025. The reporting person received 42,452 shares of common stock on net exercise of an option to purchase 187,500 shares of common stock. The Company withheld 145,048 shares of common stock underlying the option as consideration for the exercise price and tax withholdings, using the closing price on September 11, 2025 of $9.58, pursuant to the terms of the Company's 2015 Stock Option Plan.